Cases of a new COVID-19 variant, temporarily designated JN.1, are rising rapidly nationwide. According to data from the U.S. Centers for Disease Control and Prevention, JN.1 now accounts for 44% of all COVID-19 infections in the country. That represents more than double its share compared to just a week prior, highlighting the dramatic growth rate […]
- Credentialing
- Payer Contracting
- Rate Negotiations
- Medical Billing
- Specialties
- Behavioral Health
- DME
- Genetic Testing
- Urgent Care
- Pharmacogenetic (PGx) Testing
- Toxicology
- Substance Abuse
- Allergy Testing
- Speech Therapy
- Skilled Nursing Facilities
- Oncology
- Pathology
- OBGYN
- Biologics and Specialty Drugs
- Telestroke and Teleneurology
- Digital Therapeutics (DTx)
- Remote Patient Monitoring
- Remote Therapeutic Monitoring
- Home Infusion Therapy
- Sleep Study Labs
- Physical Therapy (PT)
- Occupational Therapy
- COVID-19 Testing
- Blog
- Contact